9am.health is a direct-to-consumer virtual diabetes clinic providing people living with prediabetes and type 2 diabetes with affordable medications and personalized care. The company provides easy and fully digital access to providers, labs, and medication - no matter the insurance status. For a monthly fee, patients can chat with a care team, and get medications or lab tests delivered at home. It is this packaging of medications and care into a single service that will help the company provide cheaper prices and help it stand out in the market. 9am.health kicked off in Texas and California, and is now available in 33 states.
Last round 🔗 September 16, 2021.
Select investors Founders Fund, Define Ventures, Speedinvest, iSeed Ventures
Key people 🧑🤝🧑
- Huge addressable market. Diabetes is one of the costliest, most debilitating chronic diseases in the United States, totaling more than $327 billion annually in the U.S. alone. Type 2 diabetes accounts for approximately 90 to 95 percent of the 34 million+ diabetes cases in the U.S., and an additional 88 million American adults (approximately one in three) have prediabetes. 🔗
- Straightforward business model that involves a subscription, which is good for the cash flow.
- 9am.health aims to make access to care a non-issue - rather than having patients waiting for weeks to get an appointment, the company sends them a kit with tests to their home, and then they send it back.
- Proven team with inside knowledge of the diabetes management market - they have previously started the MySugr app and sold it to Roche for $100 million in 2017.
Last update: October 3, 2021
Disclaimer: We can not guarantee that the information on this page is 100% correct. more